Morgan Brennan: SpaceX’s IPO could be the largest in history, the total addressable market is projected at $28.5 trillion, and space manufacturing will revolutionize healthcare | The Pomp Podcast
Morgan Brennan discusses SpaceX's potential IPO, which could become the largest in history with a total addressable market projected at $28.5 trillion. The discussion highlights how space manufacturing and orbital capabilities could revolutionize multiple industries, including healthcare, fundamentally transforming how goods are produced and delivered.
SpaceX's potential IPO represents a watershed moment for the aerospace and space economy sectors, signaling investor appetite for companies operating at the intersection of traditional infrastructure and cutting-edge technology. The $28.5 trillion TAM projection reflects the vast potential unlocked by reusable rocket technology and commercial space access, which Elon Musk's company has successfully demonstrated. This valuation encompasses not only launch services but the broader ecosystem of space-based manufacturing, satellite communications, and orbital infrastructure.
The space economy has evolved from government-exclusive domain to a competitive commercial sector. SpaceX's Starship program and Falcon Heavy capabilities have dramatically reduced launch costs, making space-based manufacturing economically viable. This shift parallels broader technological democratization trends where previously impossible applications become accessible through innovation. The healthcare application specifically suggests microgravity manufacturing could produce superior pharmaceuticals, crystals, or biological products impossible to create on Earth.
For traditional capital markets, a SpaceX IPO would dwarf recent mega-IPOs and potentially redirect significant institutional investment toward space infrastructure. The valuation would immediately establish space commerce as a major economic sector, attracting downstream investment in satellite companies, space tourism, and orbital stations. This creates a multiplier effect where complementary technologies and services gain investor attention and funding.
Investors should monitor regulatory approval timelines, competitive dynamics from Blue Origin and other space companies, and technical milestones for Starship. The healthcare applications represent a near-term revenue opportunity if manufacturing proves commercially viable. Market timing around a potential IPO will depend on broader economic conditions and institutional investor sentiment toward growth-stage technology companies.
- →SpaceX's potential IPO could be the largest in history, reflecting a $28.5 trillion total addressable market opportunity
- →Space manufacturing, particularly in healthcare applications, represents a significant near-term revenue driver enabled by reusable rocket technology
- →Commercial space access has transitioned from government-exclusive to competitive sector, reducing costs and expanding economic possibilities
- →A successful SpaceX IPO would establish space economy as major institutional investment category and trigger downstream funding waves
- →Regulatory approval and technical milestones for Starship program remain critical watch points for investment timing
